SILENCE THERAPEUTICS PLC-ADR (SLN)
US82686Q1013 - ADR
| TTM (2021-6-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.29M | -36.04M | -22.87M | -20.53M | -3.77M | |||
| Depreciation Amortization | 533.00K | 496.00K | 482.00K | 399.00K | 433.00K | |||
| Change In Working Capital | 35.03M | 16.81M | 23.39M | 2.73M | 3.72M | |||
| Taxes Paid | -3.02M | -3.02M | -2.31M | -1.81M | -2.01M | |||
| Other non cash items | 12.05M | 7.96M | 722.00K | 642.00K | -9.97M | |||
| OPERATING CASH FLOW | 2.33M | -10.78M | 1.73M | -16.76M | -9.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -570.00K | -514.00K | -9.00K | -188.00K | -173.00K | |||
| Other Investing Activity | 30.37M | 10.13M | -15.01M | -4.64M | 13.19M | |||
| INVESTING CASH FLOW | 29.80M | 9.62M | -15.02M | -4.83M | 13.01M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -402.00K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 30.93M | 15.83M | 5.27M | 341.00K | 48.00K | |||
| FINANCING CASH FLOW | 29.91M | 15.43M | 5.27M | 341.00K | 48.00K | |||
| Exchange Rate Effect | -1.11M | -336.00K | 36.00K | -2.00K | 270.00K | |||
| CHANGE IN CASH | 60.92M | 13.93M | -7.98M | -21.25M | 3.73M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 2.33M | -10.78M | 1.73M | -16.76M | -9.60M | |||
| Capital Expenditure | -570.00K | -514.00K | -9.00K | -188.00K | -173.00K | |||
| FREE CASH FLOW | 1.76M | -11.29M | 1.72M | -16.95M | -9.77M | |||
All data in GBP